378 related articles for article (PubMed ID: 30069587)
1. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.
Murasaki M; Koyama T; Kanba S; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
Psychopharmacology (Berl); 2018 Oct; 235(10):2859-2869. PubMed ID: 30069587
[TBL] [Abstract][Full Text] [Related]
2. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
Kanba S; Murasaki M; Koyama T; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
BMC Psychiatry; 2019 Jun; 19(1):198. PubMed ID: 31242884
[TBL] [Abstract][Full Text] [Related]
3. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial.
Li H; Gu N; Zhang H; Wang G; Tan Q; Yang F; Ning Y; Zhang H; Lu Z; Xu X; Shi J; Gao C; Li L; Zhang K; Tian H; Wang X; Li K; Li H; Xu Y; Xie S; Yu X
Psychopharmacology (Berl); 2016 Apr; 233(7):1289-97. PubMed ID: 26911380
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
[TBL] [Abstract][Full Text] [Related]
7. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
8. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.
Mezhebovsky I; Mägi K; She F; Datto C; Eriksson H
Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803
[TBL] [Abstract][Full Text] [Related]
11. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
Garriga M; Solé E; González-Pinto A; Selva-Vera G; Arranz B; Amann BL; Saiz-Ruiz J; Pérez-Blanco J; Vieta E
Eur Neuropsychopharmacol; 2017 Oct; 27(10):959-969. PubMed ID: 28882405
[TBL] [Abstract][Full Text] [Related]
14. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine: a review of its use in the management of bipolar depression.
Sanford M; Keating GM
CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
19. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
20. Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
Weisler R; Joyce M; McGill L; Lazarus A; Szamosi J; Eriksson H;
CNS Spectr; 2009 Jun; 14(6):299-313. PubMed ID: 19668121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
